AU2001233238A1 - Animal model for testing of immunotherapies - Google Patents

Animal model for testing of immunotherapies

Info

Publication number
AU2001233238A1
AU2001233238A1 AU2001233238A AU3323801A AU2001233238A1 AU 2001233238 A1 AU2001233238 A1 AU 2001233238A1 AU 2001233238 A AU2001233238 A AU 2001233238A AU 3323801 A AU3323801 A AU 3323801A AU 2001233238 A1 AU2001233238 A1 AU 2001233238A1
Authority
AU
Australia
Prior art keywords
immunotherapies
testing
animal model
animal
model
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233238A
Inventor
Margalit B. Mokyr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois
Original Assignee
University of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois filed Critical University of Illinois
Publication of AU2001233238A1 publication Critical patent/AU2001233238A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001233238A 2000-02-04 2001-02-02 Animal model for testing of immunotherapies Abandoned AU2001233238A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18025700P 2000-02-04 2000-02-04
US60/180,257 2000-02-04
PCT/US2001/003383 WO2001056612A2 (en) 2000-02-04 2001-02-02 Animal model for testing of immunotherapies

Publications (1)

Publication Number Publication Date
AU2001233238A1 true AU2001233238A1 (en) 2001-08-14

Family

ID=22659792

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233238A Abandoned AU2001233238A1 (en) 2000-02-04 2001-02-02 Animal model for testing of immunotherapies

Country Status (3)

Country Link
US (1) US20010046502A1 (en)
AU (1) AU2001233238A1 (en)
WO (1) WO2001056612A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297330B2 (en) * 2000-02-04 2007-11-20 Thomas Jefferson University Low dose haptenized tumor cell and tumor cell extract immunotherapy
WO2003063802A2 (en) * 2002-02-01 2003-08-07 Thomas Jefferson University Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer
CA2489076A1 (en) * 2002-06-10 2003-12-18 Avax Technologies Inc. Cryopreservation of haptenized tumor cells
AU2004292180A1 (en) * 2003-11-13 2005-06-02 Genentech, Inc. Screening assays and methods of tumor treatment
WO2005097832A2 (en) 2004-03-31 2005-10-20 Genentech, Inc. Humanized anti-tgf-beta antibodies
CA2593191A1 (en) * 2005-01-14 2006-07-20 Avax Technologies, Inc. Method for producing a vaccine for the treatment of cancer
WO2008151037A1 (en) * 2007-05-30 2008-12-11 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Peptide-based stat inhibitor
RU2488173C1 (en) * 2012-04-26 2013-07-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии" Сибирского отделения Российской академии медицинских наук Method for creating biological model of moderate growth inhibition of tumour and metastases in lewis lung carcinoma with prolonged cyclophosphanine-induced leukopenia in mice

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290551A (en) * 1990-05-08 1994-03-01 Thomas Jefferson University Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten
WO2000031542A1 (en) * 1998-11-24 2000-06-02 Thomas Jefferson University Detection of t cell stimulating tumor antigens

Also Published As

Publication number Publication date
WO2001056612A2 (en) 2001-08-09
US20010046502A1 (en) 2001-11-29
WO2001056612A9 (en) 2002-10-24
WO2001056612A3 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2001245348A1 (en) Language model sharing
AU2001288458A1 (en) Methods for processing animal tissues
AU2002258013A1 (en) Animal model for evaluating analgesics
AU2001231202A1 (en) Methods for killing nematodes and nematode eggs using 4-phenoxy-6-aminopyrimidine derivatives
AUPR003900A0 (en) An animal decoy
AU2001271397A1 (en) Component models
AU2001234779A1 (en) Structure identification methods using mass measurements
AU2001288467A1 (en) Open system for simulation engines
AUPQ296999A0 (en) Animal carcase analysis
AU2001275007A1 (en) Methods of testing materials
AUPR068500A0 (en) Animal carcass splitting
AU2003270037A1 (en) Methods for measuring kinase activity and phosphatase activity
AU2001233238A1 (en) Animal model for testing of immunotherapies
AU2001271841A1 (en) Methods for identifying combinations of drugs
GB2367752B (en) Completely reproducible articulator
AU1177201A (en) Simulator for running animal
AU2001285252A1 (en) Analysis of binding interactions
AU2002213801A1 (en) Multi-part cat tray
AU2001287711A1 (en) Method for measurement of the activity of NO-synthase
AU2000265029A1 (en) Acquiring local signal behavior parameters
AU2001284538A1 (en) Cultivation box for shells
AU2002227252A1 (en) Animal model for flaviviridae infection
AU2001267699A1 (en) Testing of leather
AU3865400A (en) Animal model of allergies
AU2001267834A1 (en) Method of evaluating useful cattle